Experience Leucine AI.
Powered Pharma Operations

Transform Your Pharma Operations with AI-Powered Intelligence. Experience how Leucine's integrated platform brings together manufacturing, quality, and laboratory operations in one digital ecosystem. Schedule a personalized demo to see how our AI solutions can optimize your processes, ensure compliance, and drive operational excellence.

See How AI Transforms Your Shop Floor Operations.
Experience firsthand how Leucine's 10x MES digitalizes batch records, streamlines production, and provides real-time monitoring of your manufacturing operations. Schedule a personalized demo to discover how our AI-powered platform can enhance your productivity while maintaining compliance.

Experience AI-Driven Quality Management in Action.
See how Leucine's 10x QMS automates compliance workflows, streamlines change control, and ensures regulatory adherence. Schedule a demo to learn how our AI-powered platform can help you manage quality processes more efficiently while reducing compliance risks.

Discover Smart Laboratory Operations Management.
Watch how Leucine's 10x LES orchestrates your lab operations, automates documentation, and ensures data integrity. Schedule a demo to see how our AI-powered platform can accelerate your testing processes while maintaining audit-readiness.

Optimize your manufacturing processes with paperless operations
Strengthen quality management and regulatory compliance
Accelerate laboratory operations and testing workflows

Connect with a Leucine Expert

Schedule a 30-Minute Product Demo with Expert Q&A

How To Calculate Cleaning Agent Residue Limits?

Don’t risk compliance failure. Learn how to calculate Cleaning Agent Residue Limits using ADE-based methods and avoid overly conservative, outdated practices.

How To Calculate Cleaning Agent Residue Limits?
Written By
Vivek Gera
Reading Time
5
Minutes
Back to the Top
July 7, 2025
8
 mins read

Cleaning Agent is used to cleaning an Equipment. As it comes in direct contact with the Equipment used to manufacture Products, it is necessary to ensure that it doesn’t carry over to the next Product manufactured (after cleaning). Basically, it is one of the residues that are to be controlled from the contamination point of view.

Cleaning Agents, just like APIs, have toxicological parameters which are used to calculate their limits of carryover (Cleaning Agent Residue Limits). Currently, there are two prevalent approaches to evaluate the toxicological properties of the Cleaning Agents: LD50 based approach and ADE based approach (Risk-MaPP). While the LD50 based approach is more conventional and widely used, ADE based approach (Risk-MaPP) is more scientific and is expected by the regulators now. But is it compulsory to use ADE based approach? Let’s first look at the standpoint of EMA in its

Q1 (2016 Draft) − Do companies have to establish Health-Based Exposure Limits (HBELs) for all products?

A: Yes, HBELs should be established for all products. HBELs for highly hazardous products are expected to be completed in full as per the EMA guide (EMA/CHMP/CVMP/SWP/169430/2012) or equivalent. See Q2 for products/active substances considered to be highly hazardous. Products that do not fall into the highly hazardous category may be addressed as per Q4.

Q1 (2018 Final) − Do companies have to establish Health-Based Exposure Limits (HBELs) for all medicinal products?

A: Yes, HBELs should be established for all medicinal products. The toxicological or pharmacological data, on which the HBEL calculation relies, requires periodical re-assessment throughout a product’s life cycle.

Clearly, EMA has dropped in the word “medicinal” for considering HBELs. Does this explicitly means that the non-medicinal substances used in the drug manufacturing process, such as Cleaning Agents, Intermediates, Excipients, and Degragants may not require Health-Based Exposure Limits? Companies will need to decide this based on the regulatory expectations but we'll suggest to prefer the ADE based approach as it is based on science.

Nonetheless, the companies may evaluate both the approaches and compare the limits achieved. In most cases, the companies may find out that the Cleaning Agent Residue Limits achieved with the LD50 based approach may be overly conservative and stringent. This can sometimes lead to the companies deciding to not use the Cleaning Agent at all. In such cases, adopting HBELs would be a wise and acceptable choice.

So now that we have discussed the two approaches, let's see how can the limits be calculated by each approach.

ADE BASED APPROACH

Formula for MAC is same as that of the API using PDE

ARL (Allowed Residue Limit) = PDE / LDD, where LDD = Largest Daily Dose of the next Product
MAC (Maximum Allowed Carryover) = ARL X MBS, where MBS = Minimum Batch Size of the next Product
SAL (Surface Area Limit) = MAC / SSA, where SSA = Shared Surface Area between the Cleaning Agent and the next Product

Cleaning Agent Residue Limits shall be calculated for each Cleaning Agent at each Equipment individually. Let’s take an example. Assuming that there are 4 Equipment (E1, E2, E3, E4) in a facility and 7 Drug Products (P1, P2, P3, P4, P5, P6, P7) and 3 Cleaning Agents (C1, C2, C3) as per the following configuration:

LEUCINE 10X LES
Experience Seamless Cleaning Validation
Automate cleaning validations, reduce errors, ensure compliance, and validate processes confidently.
FDA TRACKER
Free FDA Form 483 Analytics Tool
Mitigate compliance risks in your pharma processes with our large repository of in-depth insights
Back

How To Calculate Cleaning Agent Residue Limits?

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Dive Deep into the Following Critical Aspects

Documentation

Ensure all records are complete, accurate, and easily accessible.

Process and System Review

Evaluate the efficiency and effectiveness of your processes and systems.

Regulatory Compliance

Verify adherence to all relevant regulations and standards.

Facility and Personnel

Assess the condition of your facilities and the competence of your staff.

Communication & Coordination

Check the effectiveness of internal and external communication channels.

Follow-up and Monitoring

Ensure ongoing tracking and resolution of CAPAs to maintain compliance.

Back

How To Calculate Cleaning Agent Residue Limits?

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Key Areas to Strengthen Your Cleaning Validation Program

Documentation

Ensure all cleaning protocols, risk assessments, swab tests, & validation studies are well-documented & audit-ready.

Process & Risk-Based Validation

Validate cleaning processes using scientific justification, HBEL-based limits, and worst-case residue analysis.

Regulatory Alignment

Stay current with evolving expectations from FDA, EMA, WHO, MHRA, and PIC/S with harmonized practices.

Personnel Competency

Prevent errors and non-compliance with systematic training, competency assessments, & aseptic behavior compliance.

Internal Audit & Monitoring

Conduct proactive internal audits and monitor corrective actions to prevent recurrence of cleaning-related deviations.

Data-Driven Decision Making

Leverage AI tools like FDA Tracker and CLEEN to analyze gaps, monitor status, and optimize cleaning validation workflows.

Related Resources
Achieve Effortless Cleaning Validation Compliance
Pharmaceutical manufacturers trust Leucine’s Cleaning Validation software to ensure consistent, structured, and audit-ready validation processes. Say goodbye to manual errors and compliance headaches—adopt a smarter approach today